PDL BioPharma Inc. (PDLI) announced revenue guidance for its fourth quarter. The company expects revenue of approximately $57 million compared to $69 million for the fourth quarter of 2008.
Analysts polled by Thomson Reuters expect the company to report revenue of $60.61 million for the quarter.
For comments and feedback: editorial@rttnews.com